# Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis

> **NCT02784262** · PHASE2 · COMPLETED · sponsor: **Norwegian University of Science and Technology** · enrollment: 11 (actual)

## Conditions studied

- Chronic Disease
- Nasal Polyposis
- Rhinitis

## Interventions

- **DRUG:** botox injection Multiguide

## Key facts

- **NCT ID:** NCT02784262
- **Lead sponsor:** Norwegian University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-09-04
- **Final completion:** 2018-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-11-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784262, "Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02784262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*